期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Inhibitory effect of medicinal plant-derived carboxylic acids on the human transporters hOAT1, hOAT3, hOATP1B1, and hOATP2B1
1
作者 ZHANG Zhi-Yu SI Duan-Yun +1 位作者 YI Xiu-Lin LIU Chang-Xiao 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2014年第2期131-138,共8页
A significant number of organic carboxylic acids have been shown to influence the absorption and distribution of drugs mediated by organic anion transporters(OATs). In this study, uptake experiments were performed to ... A significant number of organic carboxylic acids have been shown to influence the absorption and distribution of drugs mediated by organic anion transporters(OATs). In this study, uptake experiments were performed to assess the inhibitory effects of cinnamic acid, ferulic acid, oleanolic acid, deoxycholic acid, and cynarin on hOAT1, hOAT3, hOATP1B1, and hOATP2B1. After a drug-drug interaction(DDI) investigation, cinnamic acid, ferulic acid, deoxycholic acid, and cynarin were found and validated to inhibit hOAT1 in a competitive manner, and deoxycholic acid was found to be an inhibitor of all four transporters. The apparent 50% inhibitory concentrations of cinnamic acid, ferulic acid, deoxycholic acid, and cynarin were estimated to be 133.87, 3.69, 90.03 and 6.03 μmol L 1for hOAT1, respectively. The apparent 50% inhibitory concentrations of deoxycholic acid were estimated to be 9.57 μmol L 1for hOAT3, 70.54 μmol L 1for hOATP1B1, and 168.27 μmol L 1for hOATP2B1. Because cinnamic acid, ferulic acid, and cynarin are ingredients of food or food additives, the present study suggests there are new food-drug interactions to be disclosed. In addition, deoxycholic acid may be used as a probe for studying the correlation of OATs and OATPs. 展开更多
关键词 hOAT1 hOAT3 hOATP1B1 hoatp2b1 TRANSPORT Food-drug interactions
原文传递
抗乙肝候选新药替芬泰的体外转运机制研究 被引量:9
2
作者 樊慧蓉 慈小燕 +5 位作者 李薇 曾勇 伊秀林 司端运 刘昌孝 梁光义 《药学学报》 CAS CSCD 北大核心 2016年第8期1233-1239,共7页
抗乙肝候选新药替芬泰(Y101)是一类苯丙氨酸二肽衍生物,有良好的抗乙肝病毒作用。在临床前药代动力学评价研究中发现灌胃给予大鼠Y101后,在大鼠体内的吸收、分布特征可能均与其跨膜转运有关联。本研究应用Caco-2细胞和基因转染细胞模型M... 抗乙肝候选新药替芬泰(Y101)是一类苯丙氨酸二肽衍生物,有良好的抗乙肝病毒作用。在临床前药代动力学评价研究中发现灌胃给予大鼠Y101后,在大鼠体内的吸收、分布特征可能均与其跨膜转运有关联。本研究应用Caco-2细胞和基因转染细胞模型MDCK-MDR1,通过测定Y101的表观通透系数(P_(app))和外排率(R_E),研究Y101与P-gp的相互作用,结果表明Y101为P-gp的底物。此外,应用基因转染细胞模型HEK293-h OATP1B1、HEK293-h OATP2B1和CHO-PEPT1,探讨Y101与OATP1B1、OATP2B1和PEPT1转运体的亲和性,结果显示Y101对OATP1B1和OATP2B1两种转运体有弱的抑制作用,且Y101可能不是PEPT1、OATP1B1和OATP2B1的底物。上述结果不仅可以用来解释Y101给药后体内出现的吸收、分布特征,而且可以为Y101的进一步开发提供理论依据。 展开更多
关键词 替芬泰 体外转运机制 基因转染细胞 MDCK-MDR1 HEK293-hOATP1B1 HEK293-hoatp2b1 CHO-PEPT1
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部